Interplay Between the Toxic Effects of Anticancer Drugs and Host Antitumor Immunity in Cancer Therapy

This publication has 27 references indexed in Scilit:

• Oxazaphosphorines as biological response modifiers-experimental and clinical perspectives
  Cancer Treatment Reviews, 1985
• Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients
  Cancer, 1985
• Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor
  International Journal of Immunopharmacology, 1985
• Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study
  Cancer, 1984
• Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer
  The American Journal of Medicine, 1982
• Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
  New England Journal of Medicine, 1981
• Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
  The Journal of Experimental Medicine, 1979
• Tumor immunity directed against MOPC 104E: Effect of various therapeutic regimens
  Cancer Immunology, Immunotherapy, 1977
• INDUCTION OF TUMOR IMMUNITY BY INTRATUMORAL CHEMOTHERAPY
  Annals of the New York Academy of Sciences, 1976
• Host immune potentiation of drug responses to a murine mammary adenocarcinoma
  International Journal of Cancer, 1976